Amgen seeks cancer approval for bone loss drug

Amgen seeks cancer approval for bone loss drug
Amgen Inc. said Friday it filed a new marketing application for its drug candidate denosumab, asking regulators to approve it as a treatment for bone damage suffered by cancer patients.

Read more on AP via Yahoo! News

More Meth Drug Addiction Info:

• Mexican candidate killed in drug-plagued region | p2p4u Network …
• Life Insurance Policies For Cancer Patients | Insurance Tips
• Explode Your Business With Fresh Network Marketing Leads « Stay …
• How many cancer patients are choosing cannabis over drugs …
• Jeff Burrows' Drum Marathon To Help Cancer Patients | Samaritan …
• Centrifuge: the new marketing funnel? | Eyeblaster Creative Zone …
• Alder Seeks to Treat Cancer in a Radical Way, Fighting …
• Does anyone have more information on gum disease and surgery …
• Long bone cyst in Surgical the left thigh? – Provide free health …
• Customer Service is the New Marketing « Social Media Monitoring …